InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Browse the full record of transactions filed by Griffiths Jane. Officer active across 1 company, notably LAKEFRONT BIOTHERAPEUTICS. Aggregated, 3 disclosures have been published. Activity tracked since 22 January 2026. The latest transaction was disclosed on 22 January 2026 (Purchase). Regulator: FSMA. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条